Vinicius de Toledo Ribas
http://lattes.cnpq.br/7948864772503462
Áreas de pesquisa: Neurodegeneração, regeneração e terapia gênica.
Produtos, Patentes e Publicações relevantes:
1. Da Silva VBR, Porcionatto MA, Ribas VT. (2019) The Rise of CNS Regenerative Drugs. J Med Chem. [Epub ahead of print]
2. Balke D, Tatenhorst L, Dambeck V, Ribas VT, Vahsen BF, Michel U, Bahr M, Lingor P. (2019) AAV-mediated expression of dominant negative ULK1 increases neuronal survival and enhances motor performance in the MPTP mouse model of Parkinson’s disease. Mol Neurobiol. [Epub ahead of print]
3. Ribas VT, Costa MR. (2017) Gene Manipulation Strategies to Identify Molecular Regulators of Axon Regeneration in the Central Nervous System. Front Cell Neurosci. 11:231.
4. Ribas VT, Koch JC, Michel U, Bähr M, Lingor P. (2017) Attenuation of axonal degeneration by calcium channel inhibitors improves retinal ganglion cell survival and regeneration after optic nerve crush. Mol Neurobiol. 54:76-82
5. Challagundla M, Koch JC, Ribas VT, Michel U, Kügler S, Ostendorf T, Bradke F, Müller HW, Bähr M, Lingor P. (2015) AAV-mediated expression of BAG1 and ROCK2-shRNA promote neuronal survival and axonal sprouting in a rat model of rubrospinal tract injury. J Neurochem 134(2):261-75.
6. Saal KA, Koch JC, Tatenhorst L, Szegő EM, Ribas VT, Michel U, Bähr M, Tönges L, Lingor P. (2015) AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo. Neurobiol Dis 73:150-62.
7. Ribas VT, Schnepf B, Challagundla M, Koch JC, Bähr M, Lingor P. (2015) Early and sustained activation of autophagy in degenerating axons after spinal cord injury. Brain Pathol 25(2):157-70.
E-mail: ribasvt@ufmg.br
Áreas de pesquisa: Neurodegeneração, regeneração e terapia gênica.
Produtos, Patentes e Publicações relevantes:
1. Da Silva VBR, Porcionatto MA, Ribas VT. (2019) The Rise of CNS Regenerative Drugs. J Med Chem. [Epub ahead of print]
2. Balke D, Tatenhorst L, Dambeck V, Ribas VT, Vahsen BF, Michel U, Bahr M, Lingor P. (2019) AAV-mediated expression of dominant negative ULK1 increases neuronal survival and enhances motor performance in the MPTP mouse model of Parkinson’s disease. Mol Neurobiol. [Epub ahead of print]
3. Ribas VT, Costa MR. (2017) Gene Manipulation Strategies to Identify Molecular Regulators of Axon Regeneration in the Central Nervous System. Front Cell Neurosci. 11:231.
4. Ribas VT, Koch JC, Michel U, Bähr M, Lingor P. (2017) Attenuation of axonal degeneration by calcium channel inhibitors improves retinal ganglion cell survival and regeneration after optic nerve crush. Mol Neurobiol. 54:76-82
5. Challagundla M, Koch JC, Ribas VT, Michel U, Kügler S, Ostendorf T, Bradke F, Müller HW, Bähr M, Lingor P. (2015) AAV-mediated expression of BAG1 and ROCK2-shRNA promote neuronal survival and axonal sprouting in a rat model of rubrospinal tract injury. J Neurochem 134(2):261-75.
6. Saal KA, Koch JC, Tatenhorst L, Szegő EM, Ribas VT, Michel U, Bähr M, Tönges L, Lingor P. (2015) AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo. Neurobiol Dis 73:150-62.
7. Ribas VT, Schnepf B, Challagundla M, Koch JC, Bähr M, Lingor P. (2015) Early and sustained activation of autophagy in degenerating axons after spinal cord injury. Brain Pathol 25(2):157-70.
E-mail: ribasvt@ufmg.br